Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy

1. Auflage 2023
ISBN: 978-3-030-64476-5
Verlag: Springer International Publishing

Buch, Englisch, 1336 Seiten, HC runder Rücken kaschiert, Format (B × H): 183 mm x 260 mm, Gewicht: 3299 g

This encyclopedia covers the definitions, concepts, methods, theories, and application of evidence-based pharmaceutical public health and health services research. It highlights why and how this field has a significant impact on healthcare. The work aims to synthesize baseline knowledge as well as the latest and cutting-edge research-based information. The encyclopedia collates information on public health, health services research, evidence-based pharmacy practice and its impacts on patients, decision-makers and consumers. This reference work discusses all aspects of policy and practice decisions on medicines use, access and pharmacy services by covering broad aspects related to pharmacy practice, public health and health services research. The aim is to develop high-quality content, which will be a must-read and be used as a reference source at all pharmacy and medical schools in the world.

The health services research investigates the impact of social factors, organizational policies, financing systems, medical technologies and personal influence on access, quality and cost of healthcare concerning the quality of life of the patients. This reference work fundamentally promotes the evidence-based evaluation of healthcare services and thus will improve the better access and delivery of healthcare services. Also, pharmacy, medical and health services students and researchers need a broad understanding of pharmaceutical public health, evidence-based approaches to delivering care, changing professional and patient behavior and undertaking research in these areas. In general, there is a need to build research capacity and capability in the pharmacy profession.

EDITOR-IN-CHIEF:

Professor Zaheer-Ud-Din Babar, University of Huddersfield
SECTION EDITORS:

Filipa Alves da Costa, University of LisbonZubin Austin, University of TorontoDalia Dawood, National Institute for Health and Care Excellence Andy Gray, University of Kwa Zulu-NatalRachele Hendricks-Sturrup, Duke Margolis Center for Health PolicyJason Hsu, Taiwan Medical UniversityRabia Hussain, Universiti Sains MalaysiaChristine Y. Lu, Harvard Medical School and Harvard Pilgrim Health Care InstituteMohamed Izham Mohamed Ibrahim, Qatar UniversityPrasad Nishtala, University of BathDerek Charles Stewart, College of Pharmacy, Qatar University
Fatima Suleman, University of Kwa Zulu-NatalZaheer-Ud-Din Babar, University of Huddersfield

Zielgruppe

Research

Autoren/Hrsg.

Weitere Mitwirkende

Babar, Zaheer-Ud-Din

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Public Health, Gesundheitsmanagement, Gesundheitsökonomie, Gesundheitspolitik
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie

Inhaltsverzeichnis

Global Changes, Development, Evidence and Impact in General.- Evident and Impact of Health Services Research and Pharmaceutical Public Health.- Evidence andIimpact of Pharmacoepidemiology and Pharmacovigilance Research.- Evidence and Impact of Research Methodologies Used in Health Services Research in Pharmacy and Pharmaceutical Public Health.- Evidence and Impact of Health Services Research in Pharmacy and Pharmaceutical Public Health in High Income Countries.- Evidence and Impact of Health Services Research in Pharmacy and Pharmaceutical Public Health in LMICs.- Evidence and Impact of Health Services Research in Pharmacy and Pharmaceutical Public Health in the UK.- Evidence and Impace of Pharmacoeconomics Research.- Evidence and Impact of Interventions, Medicines and Medical Technologies in COVID-19 and Other Pandemics.- Evidence and Impact of “Medicines Access and Use Research”.- Evidence and Impact of Research Related to Pharmacogenomics and Precision Medicine

Über Autor(innen)

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare and the Director of the Centre of Pharmaceutical Policy and Practice Research at the University of Huddersfield, United Kingdom. A pharmacist by training, Prof Babar is the recipient of the prestigious “Research Excellence Award “ from the University of Auckland. He understands the health systems and pharmacy globally and is known for his work in pharmaceutical policy and practice, including quality use of medicines, evidence and impact, access to medicines, medicine prices and issues related to pharmacoeconomics. He has published in high impact journals such as PLoS Medicine and Lancet and has acted as a consultant for World Health Organization, Royal Pharmaceutical Society, Health Action International, International Union Against Tuberculosis and Lung Disease, World Bank, International Pharmaceutical Federation (FIP) and for the Pharmaceutical Management Agency of New Zealand. His edited work includes "Economic evaluation of pharmacy services", “Pharmaceutical prices in the 21st century”, “Pharmaceutical policies in countries with developing healthcare systems ", “Global Pharmaceutical Policy”, "Equitable access to high-cost medicines" “Pharmacy Practice Research Methods”, “Social and Administrative Aspects of Pharmacy in Low and Middle-Income Countries” and the “Encyclopedia of Pharmacy Practice and Clinical Pharmacy”. Published by Elsevier and Adis/Springer, the books are used in curriculum design, policy development and for referral all around the globe. Professor Babar is the Editor-in-Chief of the BMC Journal of Pharmaceutical Policy and Practice and can be contacted at [e-mail]